Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
IMMURON (IMRN) had Cash Flow from Financial Activities of $-0.03M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$7.66M |
|
$0.09M |
|
$0.27M |
|
$7.92M |
|
$1.13M |
|
-- |
|
$0.07M |
|
$1.19M |
|
$6.73M |
|
$6.73M |
|
$6.73M |
|
5.73M |
|
| Cash Flow Statement Financials | |
$-2.60M |
|
$0.04M |
|
|
Cash Flow from Financial Activities |
$-0.03M |
$7.59M |
|
$5.04M |
|
$-2.55M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|